Skip to content

Clinical trials

Observational Respiratory Distress Syndrome trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Phase: Observational Country / region: China Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20123
20131
20142
20154
20162
20174
20183
20194
20202
20217
20225
20238
20246
20256
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Unknown status19
Recruiting14
Not yet recruiting3
Enrolling by invitation2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Southeast University, China10
Peking Union Medical College Hospital4
Shanghai Zhongshan Hospital4
Beijing Anzhen Hospital3
Beijing Chao Yang Hospital3
China-Japan Friendship Hospital3
Zhongda Hospital3
Changhai Hospital2
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University2
Ruijin Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome64
Acute Lung Injury7
Respiratory Insufficiency5
Sepsis5
Critical Illness3
Respiratory Aspiration3
COVID-192
Heart Arrest2
Heart Failure2
Inflammation2

Trials

Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.